Back to Journals » Journal of Pain Research » Volume 4

Cortical NR2B NMDA subunit antagonism reduces inflammatory pain in male and female rats

Authors Quintero G, Herrera, Bethancourt

Published 26 September 2011 Volume 2011:4 Pages 301—308

DOI https://doi.org/10.2147/JPR.S24703

Review by Single-blind

Peer reviewer comments 3


Gabriel C Quintero1, Jairo Herrera1,2, José Bethancourt1
1Institute of Scientific Research and High Technology Services (INDICASAT-AIP), Center for Neurosciences, Panama; 2Academic Direction of Psychology, Interamerican University of Panama, Panama

Background: Studies have shown that N-methyl-D-aspartate (NMDA) receptors play a critical role in pain processing at different levels of the central nervous system.
Methods: In this study, we used adult Wistar rats to examine gender differences in the effects of NR2B NMDA antagonism at the level of the anterior cingulate cortex in phasic pain, and in the first and second phases of a formalin test. Rats underwent stereotactic surgery for cannula implantation in the anterior cingulate cortex. After recovery, paw withdrawal latency to a noxious thermal stimulus was assessed. Rats were also subjected to a formalin pain test whereby 60 µL of 5% formalin was injected into the right hind paw.
Results: Female and male rats that received Ro 25-6981, an NR2B antagonist, before formalin injection showed significantly reduced pain responses to the formalin test compared with saline-injected control rats (P < 0.05). No gender differences in phasic pain responses were found in rats treated with Ro 25-6981.
Conclusion: These results suggest that cortical antagonism of the NR2B subunit reduces inflammatory pain levels in both genders of rat.

Keywords: cingulate cortex, NMDA receptor, NR2B protein, rats, gender

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]